Laezza C - Search Results

1

N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux.

Ranieri R, Ciaglia E, Amodio G, Picardi P, Proto MC, Gazzerro P, Laezza C, Remondelli P, Bifulco M, Pisanti S. Ranieri R, et al. Among authors: laezza c. Cell Death Differ. 2018 Feb;25(2):353-367. doi: 10.1038/cdd.2017.165. Epub 2017 Oct 13. Cell Death Differ. 2018. PMID: 29027991 Free PMC article.

2

Thyrotropin modulates low density lipoprotein binding activity in FRTL-5 thyroid cells.

Bifulco M, Santillo M, Tedesco I, Zarrilli R, Laezza C, Aloj SM. Bifulco M, et al. Among authors: laezza c. J Biol Chem. 1990 Nov 5;265(31):19336-42. J Biol Chem. 1990. PMID: 2229079 Free article.

3

Mevalonate controls cytoskeleton organization and cell morphology in thyroid epithelial cells.

Bifulco M, Laezza C, Aloj SM, Garbi C. Bifulco M, et al. Among authors: laezza c. J Cell Physiol. 1993 May;155(2):340-8. doi: 10.1002/jcp.1041550215. J Cell Physiol. 1993. PMID: 8482726

4

N6-isopentenyladenosine affects cAMP-dependent microfilament organization in FRTL-5 thyroid cells.

Laezza C, Migliaro A, Cerbone R, Tedesco I, Santillo M, Garbi C, Bifulco M. Laezza C, et al. Exp Cell Res. 1997 Jul 10;234(1):178-82. doi: 10.1006/excr.1997.3610. Exp Cell Res. 1997. PMID: 9223384

5

Identification of a 48-kDa prenylated protein that associates with microtubules as 2',3'-cyclic nucleotide 3'-phosphodiesterase in FRTL-5 cells.

Laezza C, Wolff J, Bifulco M. Laezza C, et al. FEBS Lett. 1997 Aug 18;413(2):260-4. doi: 10.1016/s0014-5793(97)00924-1. FEBS Lett. 1997. PMID: 9280293 Free article.

6

The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.

De Petrocellis L, Melck D, Palmisano A, Bisogno T, Laezza C, Bifulco M, Di Marzo V. De Petrocellis L, et al. Among authors: laezza c. Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8375-80. doi: 10.1073/pnas.95.14.8375. Proc Natl Acad Sci U S A. 1998. PMID: 9653194 Free PMC article.

7

Control of Rab5 and Rab7 expression by the isoprenoid pathway.

Laezza C, Bucci C, Santillo M, Bruni CB, Bifulco M. Laezza C, et al. Biochem Biophys Res Commun. 1998 Jul 30;248(3):469-72. doi: 10.1006/bbrc.1998.9007. Biochem Biophys Res Commun. 1998. PMID: 9703948

8

v-K-ras leads to preferential farnesylation of p21(ras) in FRTL-5 cells: multiple interference with the isoprenoid pathway.

Laezza C, Di Marzo V, Bifulco M. Laezza C, et al. Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13646-51. doi: 10.1073/pnas.95.23.13646. Proc Natl Acad Sci U S A. 1998. PMID: 9811854 Free PMC article.

9

Prenyltransferase inhibitors induce apoptosis in proliferating thyroid cells through a p53-independent CrmA-sensitive, and caspase-3-like protease-dependent mechanism.

Vitale M, Di Matola T, Rossi G, Laezza C, Fenzi G, Bifulco M. Vitale M, et al. Among authors: laezza c. Endocrinology. 1999 Feb;140(2):698-704. doi: 10.1210/endo.140.2.6494. Endocrinology. 1999. PMID: 9927296

10

Inhibition of farnesylation blocks growth but not differentiation in FRTL-5 thyroid cells.

Bifulco M, Laezza C, Aloj SM. Bifulco M, et al. Among authors: laezza c. Biochimie. 1999 Apr;81(4):287-90. doi: 10.1016/s0300-9084(99)80072-8. Biochimie. 1999. PMID: 10401660

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters